huCCL1(BALB/c) Mouse
製品名
huCCL1(BALB/c) Mouse
製品ID
C001989
系統名
BALB/cAnCya-Ccl1tm1(hCCL1)/Cya
背景情報
BALB/cAnCya
状況
このマウス系統を論文で使用する場合は、「huCCL1(BALB/c) Mouse（カタログ番号C001989）はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
遺伝子名
遺伝子別名
P500, SISe, TCA3, I-309, SCYA1
NCBI ID
染色体
Chr 17
MGI ID
さらに
系統詳細
C-C motif chemokine ligand 1 (CCL1), also known as I-309, is a small chemokine mainly secreted by activated T cells, monocytes, and endothelial cells. It belongs to the CC chemokine family and plays a key regulatory role in Th2-type immune responses and the recruitment of regulatory T cells (Tregs) [1]. CCL1 binds to its specific receptor CCR8 (C-C chemokine receptor type 8) to mediate the directed migration of Th2 cells and Tregs to inflammatory sites and the tumor microenvironment, promoting the formation of an immunosuppressive tumor microenvironment (TME). It is also involved in the immune regulation of allergic inflammatory responses, autoimmune diseases, and graft-versus-host disease (GvHD) [2-3]. The CCL1 gene is located on human chromosome 17 (17q12) and is closely associated with immune evasion in various solid tumors, Th2-type allergic diseases, and the development of inflammatory bowel disease (IBD). Targeting the CCL1-CCR8 signaling axis has become an important strategy for drug development in tumor immunotherapy, allergic diseases, and autoimmune disorders [4-5].
The huCCL1(BALB/c) mouse is a humanized model constructed through gene editing technology. The sequences from the start codon to the stop codon of the endogenous mouse Ccl1 gene were replaced with the sequences from the start codon to the stop codon of the human CCL1 gene. This model is suitable for evaluating the efficacy and safety of CCL1-targeted antibodies and CAR-T/CAR-NK cell therapies, as well as for preclinical research in tumor immunity, Th2/Treg immune regulation, allergic disorders, and autoimmune diseases.
参考文献
Miller MD, Krangel MS. The human cytokine I-309 is a monocyte chemoattractant. Proc Natl Acad Sci USA, 1992; 89(7): 2950–2954.
Tiffany HL, Lautens LL, Gao JL, et al. Identification of CCR8: a human monocyte and thymus receptor for the CC chemokine I-309. J Exp Med, 1997; 186(1): 165–170.
Zingoni A, Soto H, Hedrick JA, et al. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J Immunol, 1998; 161(2): 547–551.
Haque NS, Fallon JT, Pan JJ, et al. Chemokine receptor-8 (CCR8) mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion. Blood, 2004; 103(4): 1296–1304.
Eruslanov EB, Bhojnagarwala PS, Quatromoni JG, et al. Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J Clin Invest, 2014; 124(12): 5466–5480.
系統作製戦略
The sequences from the start codon to the stop codon of the endogenous mouse Ccl1 gene were replaced with the sequences from the start codon to the stop codon of the human CCL1 gene.
Figure 1. Gene editing strategy of huCCL1(BALB/c) mice.
適用分野
Screening, development, and preclinical evaluation of CCL1-targeted therapeutics;
Immune and inflammatory research;
Tumor immunotherapy and microenvironment research;
Autoimmune disease research;
Chemokine signaling pathway research;
Evaluation of antibody therapeutics and small-molecule inhibitors.
お問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。